800 related articles for article (PubMed ID: 22729761)
1. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
2. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.
Godawat R; Brower K; Jain S; Konstantinov K; Riske F; Warikoo V
Biotechnol J; 2012 Dec; 7(12):1496-508. PubMed ID: 23070975
[TBL] [Abstract][Full Text] [Related]
3. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
4. Process performance and product quality in an integrated continuous antibody production process.
Karst DJ; Steinebach F; Soos M; Morbidelli M
Biotechnol Bioeng; 2017 Feb; 114(2):298-307. PubMed ID: 27497430
[TBL] [Abstract][Full Text] [Related]
5. A new large-scale manufacturing platform for complex biopharmaceuticals.
Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
[TBL] [Abstract][Full Text] [Related]
6. Continuous and Integrated Expression and Purification of Recombinant Antibodies.
Vogg S; Wolf MKF; Morbidelli M
Methods Mol Biol; 2018; 1850():147-178. PubMed ID: 30242686
[TBL] [Abstract][Full Text] [Related]
7. Integrated continuous biomanufacturing platform with ATF perfusion and one column chromatography operation for optimum resin utilization and productivity.
Kamga MH; Cattaneo M; Yoon S
Prep Biochem Biotechnol; 2018 May; 48(5):383-390. PubMed ID: 29509101
[TBL] [Abstract][Full Text] [Related]
8. Bioreactor systems for the production of biopharmaceuticals from animal cells.
Warnock JN; Al-Rubeai M
Biotechnol Appl Biochem; 2006 Jul; 45(Pt 1):1-12. PubMed ID: 16764553
[TBL] [Abstract][Full Text] [Related]
9. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.
Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP
Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088
[TBL] [Abstract][Full Text] [Related]
10. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system.
Kim BJ; Chang HN; Oh DJ
Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812
[TBL] [Abstract][Full Text] [Related]
11. Production of a secreted glycoprotein from an inducible promoter system in a perfusion bioreactor.
Lipscomb ML; Mowry MC; Kompala DS
Biotechnol Prog; 2004; 20(5):1402-7. PubMed ID: 15458323
[TBL] [Abstract][Full Text] [Related]
12. Development of a new bioprocess scheme using frozen seed train intermediates to initiate CHO cell culture manufacturing campaigns.
Seth G; Hamilton RW; Stapp TR; Zheng L; Meier A; Petty K; Leung S; Chary S
Biotechnol Bioeng; 2013 May; 110(5):1376-85. PubMed ID: 23242970
[TBL] [Abstract][Full Text] [Related]
13. High cell density fed batch and perfusion processes for stable non-viral expression of secreted alkaline phosphatase (SEAP) using insect cells: comparison to a batch Sf-9-BEV system.
Jardin BA; Montes J; Lanthier S; Tran R; Elias C
Biotechnol Bioeng; 2007 Jun; 97(2):332-45. PubMed ID: 17054119
[TBL] [Abstract][Full Text] [Related]
14. An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer.
McLeod J; O'Callaghan PM; Pybus LP; Wilkinson SJ; Root T; Racher AJ; James DC
Biotechnol Bioeng; 2011 Sep; 108(9):2193-204. PubMed ID: 21445882
[TBL] [Abstract][Full Text] [Related]
15. An integrated process for mammalian cell perfusion cultivation and product purification using a dynamic filter.
Castilho LR; Anspach FB; Deckwer WD
Biotechnol Prog; 2002; 18(4):776-81. PubMed ID: 12153312
[TBL] [Abstract][Full Text] [Related]
16. End-to-end integrated fully continuous production of recombinant monoclonal antibodies.
Godawat R; Konstantinov K; Rohani M; Warikoo V
J Biotechnol; 2015 Nov; 213():13-9. PubMed ID: 26073998
[No Abstract] [Full Text] [Related]
17. Defining process design space for monoclonal antibody cell culture.
Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
[TBL] [Abstract][Full Text] [Related]
18. Design and operation of a continuous integrated monoclonal antibody production process.
Steinebach F; Ulmer N; Wolf M; Decker L; Schneider V; Wälchli R; Karst D; Souquet J; Morbidelli M
Biotechnol Prog; 2017 Sep; 33(5):1303-1313. PubMed ID: 28691347
[TBL] [Abstract][Full Text] [Related]
19. A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.
Legmann R; Schreyer HB; Combs RG; McCormick EL; Russo AP; Rodgers ST
Biotechnol Bioeng; 2009 Dec; 104(6):1107-20. PubMed ID: 19623562
[TBL] [Abstract][Full Text] [Related]
20. Development of at-line assay to monitor charge variants of MAbs during production.
St Amand MM; Ogunnaike BA; Robinson AS
Biotechnol Prog; 2014; 30(1):249-55. PubMed ID: 24382831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
